AbbVie Inc. (NEO:ABBV)
Canada · Delayed Price · Currency is CAD 27.91
-0.42 (-1.48%)
Aug 6, 2025, 9:30 AM EDT
Regulus Therapeutics Market Cap
AbbVie has a market cap or net worth of CAD 483.44 billion as of August 6, 2025. Its market cap has increased by 14.60% in one year.
Market Cap
483.44B
Enterprise Value
571.87B
Revenue
79.55B
Ranking
n/a
PE Ratio
95.21
Stock Price
$27.91
Market Cap Chart
Since December 10, 2012, AbbVie's market cap has increased from 54.62B to 483.44B, an increase of 785.13%. That is a compound annual growth rate of 18.79%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 6, 2025 | 476.53B | 5.47% |
| Dec 31, 2024 | 451.83B | 25.04% |
| Dec 29, 2023 | 361.33B | -6.56% |
| Dec 30, 2022 | 386.68B | 27.65% |
| Dec 31, 2021 | 302.92B | 25.67% |
| Dec 31, 2020 | 241.04B | 41.93% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Green Thumb Industries | 2.16B |
| Sienna Senior Living | 1.65B |
| dentalcorp Holdings | 1.57B |
| Curaleaf Holdings | 1.50B |
| Trulieve Cannabis | 1.24B |
| WELL Health Technologies | 1.17B |
| Cronos Group | 1.04B |
| Extendicare | 1.03B |